Ellab has appointed Gergely Sved as its new chief executive officer (CEO) following the departure of Ludvig Enlund.

Swedish biotechnology company Asgard Therapeutics has appointed Shane Olwill as chief development officer (CDO) to further its work on in vivo direct cell reprogramming for cancer immunology.

Berlin-based ProBioGen has appointed its former chief operating officer (COO) Alfred Merz to be its new chief executive officer (CEO), a role he had previously been holding on an interim basis.

AAX Biotech has made two key appointments as it seeks to further develop its research efforts and business presence.

CluePoints has appointed Usama Dar as its new chief product and technology officer.

UK-based consultancy-led organisation Coronado Research has announced that it has appointed Gary Lyons as executive vice president (EVP) for medical affairs.

ViCentra, a company focused on its automated insulin delivery system, has announced the appointment of Tom Arnold as chief executive officer.

Eleva, a clinical-stage biopharmaceutical company, has announced the appointment of Martin Bauer as its new chief medical officer.

Novo Nordisk has announced the appointment of Sebnem Avsar Tuna as general manager for its UK affiliate.

Glox Therapeutics, a precision medicine company spun out from the Universities of Oxford and Glasgow, has announced the appointments of Michael Murray (pictured) as chair of the board and Nel Moore as scientific advisory board member.

Sapio Sciences, a provider of lab informatics solutions, has announced the appointment of Mike Hampton as chief commercial officer and unveiled its new scientific office.

Nuclera has announced the appointment of Seth Benson as its new chief financial officer, following the strengthening of its leadership team with three key appointments at the end of last year.